These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6516411)

  • 21. What we do not know about pregnancy in hereditary neuromuscular disorders.
    Argov Z; de Visser M
    Neuromuscul Disord; 2009 Oct; 19(10):675-9. PubMed ID: 19692244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum cytoplasmic and mitochondrial aspartate aminotransferase in Duchenne's progressive muscular dystrophy.
    Janik P; Nowak I; Niebrój-Dobosz I
    Mater Med Pol; 1994; 26(3):101-4. PubMed ID: 7603078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased adenine nucleotide turnover in duchenne muscular dystrophy.
    Bertorini TE; Palmieri GM; Airozo D; Edwards NL; Fox IH
    Pediatr Res; 1981 Dec; 15(12):1478-82. PubMed ID: 7322666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers.
    Takagi A; Sunohara N; Ishihara T; Nonaka I; Sugita H
    Muscle Nerve; 1983 Sep; 6(7):510-4. PubMed ID: 6633564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscle fiber degeneration and necrosis in muscular dystrophy and other muscle diseases: cytochemical and immunocytochemical data.
    Cornelio F; Dones I
    Ann Neurol; 1984 Dec; 16(6):694-701. PubMed ID: 6524876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors.
    Blankinship MJ; Gregorevic P; Chamberlain JS
    Mol Ther; 2006 Feb; 13(2):241-9. PubMed ID: 16361117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycobiology of neuromuscular disorders.
    Martin PT; Freeze HH
    Glycobiology; 2003 Aug; 13(8):67R-75R. PubMed ID: 12736200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathology of the muscular dystrophies and the congenital nonprogressive myopathies.
    Armbrustmacher VW
    Pathol Annu; 1980; 15(Pt 1):301-33. PubMed ID: 7443308
    [No Abstract]   [Full Text] [Related]  

  • 29. Hypogonadism is common in men with myopathies.
    Al-Harbi TM; Bainbridge LJ; McQueen MJ; Tarnopolsky MA
    J Clin Neuromuscul Dis; 2008 Jun; 9(4):397-401. PubMed ID: 18525423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term nasal ventilation in neuromuscular disorders: report of a consensus conference.
    Robert D; Willig TN; Leger P; Paulus J
    Eur Respir J; 1993 Apr; 6(4):599-606. PubMed ID: 8491312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asymptomatic or minimally symptomatic hyperCKemia: histopathologic correlates.
    Dabby R; Sadeh M; Herman O; Berger E; Watemberg N; Hayek S; Jossiphov J; Nevo Y
    Isr Med Assoc J; 2006 Feb; 8(2):110-3. PubMed ID: 16544734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscular dystrophies: influence of physical conditioning on the disease evolution.
    Ansved T
    Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):435-9. PubMed ID: 12806218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral health considerations in muscular dystrophies.
    Balasubramaniam R; Sollecito TP; Stoopler ET
    Spec Care Dentist; 2008; 28(6):243-53. PubMed ID: 19068065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duchenne muscular dystrophy: unusual activation of single fibers in vitro.
    Takagi A; Nonaka I
    Muscle Nerve; 1981; 4(1):10-5. PubMed ID: 7231441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Updates in muscular dystrophies].
    Erazo-Torricelli R
    Rev Neurol; 2004 Nov 1-15; 39(9):860-71. PubMed ID: 15543503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ultrastructural features of primary myopathy].
    Bosman C; Boldrini R
    Pathologica; 2000 Apr; 92(2):108-13. PubMed ID: 10939908
    [No Abstract]   [Full Text] [Related]  

  • 37. [Molecular pathogenesis of muscular diseases].
    Ohlendieck K
    Naturwissenschaften; 1996 Dec; 83(12):555-65. PubMed ID: 9036337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperestrogenemia in neuromuscular diseases.
    Usuki F; Nakazato O; Osame M; Igata A
    J Neurol Sci; 1989 Feb; 89(2-3):189-97. PubMed ID: 2926448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiomyopathy and neuromyopathic disorders: pathological aspects.
    Olsen EG
    Proc R Soc Med; 1972 Nov; 65(11):941-3. PubMed ID: 4642015
    [No Abstract]   [Full Text] [Related]  

  • 40. [The importance of monitoring myoglobinemia in neuromuscular diseases].
    Kerndlová E; Ambler Z; Topolcan O; Dvorák I
    Cas Lek Cesk; 1987 Sep; 126(35-36):1109-11. PubMed ID: 3664583
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.